Product Information
CEFPROZIL 125 MG/5 ML SUSP is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $0.1061 per ML under NDC 68180040103. Its NADAC has been published 653 times since Nov 28, 2013.
FDA first approved this application on Dec 19, 2005. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
125 mg/5mL
Manufacturer
Lupin Pharmaceuticals Inc.NDC
68180040103
Classification
Generic
Dosage Form
POWDER, FOR SUSPENSION
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
CEFPROZILApproval Type
Generic (ANDA)
FDA Application
ANDA065261FDA Approved
12/19/2005
TE Code
AB
On Market Since
12/1/2005
Price Statistics
The NADAC for CEFPROZIL 125 MG/5 ML SUSP has been published 653 times since Nov 28, 2013, and over the history we have for it it has declined 65.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1061 per ML |
|---|---|
| All-time high | $0.3098 (Dec 11, 2013) |
| All-time low | $0.0917 (Jan 18, 2023) |
| 52-week high | $0.1421 |
| 52-week low | $0.0986 |
| Median price | $0.1869 |
| Average price | $0.1985 |
| Largest weekly change | +73.0% (May 18, 2022) |
| Weeks tracked | 653 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the CEFPROZIL market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CEFPROZIL 125 MG/5 ML SUSP?
The current National Average Drug Acquisition Cost (NADAC) for CEFPROZIL 125 MG/5 ML SUSP, manufactured by Lupin Pharmaceuticals Inc., is $0.1061 per ML (NDC 68180040103), effective Aug 19, 2026.
How has the price of CEFPROZIL 125 MG/5 ML SUSP changed over time?
Over the history we have for it, the NADAC for CEFPROZIL 125 MG/5 ML SUSP has declined 65.7%. It has been tracked across 653 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CEFPROZIL 125 MG/5 ML SUSP?
Since Nov 28, 2013, the NADAC for CEFPROZIL 125 MG/5 ML SUSP has ranged from a low of $0.0917 (Jan 18, 2023) to a high of $0.3098 (Dec 11, 2013), with a median of $0.1869 per ML.
Are there cheaper alternatives to CEFPROZIL 125 MG/5 ML SUSP?
No other NADAC-published product currently shares the active ingredient and strength of CEFPROZIL 125 MG/5 ML SUSP in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures CEFPROZIL 125 MG/5 ML SUSP?
CEFPROZIL 125 MG/5 ML SUSP (NDC 68180040103) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.